Discovery of a Novel Benzothiadiazine-Based Selective Aldose Reductase Inhibitor as Potential Therapy for Diabetic Peripheral Neuropathy.
- DOI
- 10.2337/db23-0006
- Published
- 2024 Mar 1
- Container
- Diabetes
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2337/db23-0006,
title = {Discovery of a Novel Benzothiadiazine-Based Selective Aldose Reductase Inhibitor as Potential Therapy for Diabetic Peripheral Neuropathy.},
author = {Jin R and Wang J and Li M and Tang T and Feng Y and Zhou S and Xie H and Feng H and Guo J and Fu R and Liu J and Tang Y and Shi Y and Guo H and Wang Y and Nie F and Li J},
year = {2024},
journal = {Diabetes},
doi = {10.2337/db23-0006},
url = {https://doi.org/10.2337/db23-0006}
}RIS
TY - JOUR TI - Discovery of a Novel Benzothiadiazine-Based Selective Aldose Reductase Inhibitor as Potential Therapy for Diabetic Peripheral Neuropathy. AU - Jin R AU - Wang J AU - Li M AU - Tang T AU - Feng Y AU - Zhou S AU - Xie H AU - Feng H AU - Guo J AU - Fu R AU - Liu J AU - Tang Y AU - Shi Y AU - Guo H AU - Wang Y AU - Nie F AU - Li J PY - 2024 JO - Diabetes DO - 10.2337/db23-0006 UR - https://doi.org/10.2337/db23-0006 ER -
APA
R, J., J, W., M, L., T, T., Y, F., S, Z., H, X., H, F., J, G., R, F., J, L., Y, T., Y, S., H, G., Y, W., F, N., & J, L. (2024). Discovery of a Novel Benzothiadiazine-Based Selective Aldose Reductase Inhibitor as Potential Therapy for Diabetic Peripheral Neuropathy.. Diabetes. https://doi.org/10.2337/db23-0006
Source records
- pubmed · retrieved 2026-09-24T23:39:33.493Z